Molecular Templates Inc (MTEM)

NASDAQ
5.990
-0.210(-3.39%)
After Hours
5.980
-0.010(-0.167%)
- Real-time Data
  • Volume:
    751,441
  • Bid/Ask:
    5.860/6.040
  • Day's Range:
    5.830 - 6.220

MTEM Overview

Prev. Close
6.2
Day's Range
5.83-6.22
Revenue
26.15M
Open
6.22
52 wk Range
5.7-15.19
EPS
-1.83
Volume
751,441
Market Cap
336.29M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
205,952
P/E Ratio
-
Beta
1.42
1-Year Change
-53.2%
Shares Outstanding
56,142,400
Next Earnings Date
Nov 16, 2021
What is your sentiment on Molecular Templates Inc?
or
Market is currently closed. Voting is open during market hours.

Molecular Templates Inc News

Molecular Templates Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuySellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuySellStrong SellStrong Sell
SummaryStrong BuyStrong BuySellStrong SellStrong Sell

Molecular Templates Inc Company Profile

Molecular Templates Inc Company Profile

Employees
253

Molecular Templates, Inc., formerly Threshold Pharmaceuticals, Inc., is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of therapeutic and diagnostic agents that selectively target tumor cells for the treatment of patients living with cancer. The Company also focused on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies (ETBs). The Company is developing two therapeutic product candidates based on hypoxia-activated prodrug technology: evofosfamide and tarloxotinib. The Company’s lead drug candidate MT-3724 is an is an immunotoxin that targets the CD20 cell surface antigen present in a variety of lymphomas and leukemias.

Read More
  • Gonna be in the green today!!🚀🚀🚀
    0
    • It a buy
      0
      • 24$ next stop
        0
        • Positive phase 1 results for new drug could help move this stock considerably. From what I've read, results are expected in January.
          0
          • It will reach 1$ in coming days
            0
            • Do you know about any good news?
              0
          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.